On Monday, the Federal Drug Administration in the US revoked its emergency approval of the controversial malaria drugs, hydroxychloroquine and chloroquine, for treating COVID-19, stating that the drugs are unlikely
On Monday, the Federal Drug Administration in the US revoked its emergency approval of the controversial malaria drugs, hydroxychloroquine and chloroquine, for treating COVID-19, stating that the drugs are unlikely